ResearcherSheng Jing HospitalActive in the last 2 years

Jin Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9165-1962; OpenAlex author ID A5101602967. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Letter to the Editor of Annals of Surgical Oncology Concerning "Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperat… First author DOI 10.1245/s10434-025-17743-6 ↗
LncRNA MIR99AHG mediated by FOXA1 modulates NOTCH2/Notch signaling pathway to accelerate pancreatic cancer through sponging miR-3129-5p and recruiting ELAVL1. Co-author DOI 10.1186/s12935-021-02189-z ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Heyue Zhang · 1 shared paper, 2025 · strength 0.33
- Paper Letter to the Editor of Annals of Surgical Oncology Concerning "Dissecting Tumor Size Underestimation in Pancreatic Can… DOI 10.1245/s10434-025-17743-6 ↗
Hailin Tang · 1 shared paper, 2025 · strength 0.33
- Paper Letter to the Editor of Annals of Surgical Oncology Concerning "Dissecting Tumor Size Underestimation in Pancreatic Can… DOI 10.1245/s10434-025-17743-6 ↗
Qinyun Sun · 1 shared paper, 2021 · strength 0.16
- Paper LncRNA MIR99AHG mediated by FOXA1 modulates NOTCH2/Notch signaling pathway to accelerate pancreatic cancer through spon… DOI 10.1186/s12935-021-02189-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.